Sanofi Competitors and Similar CompaniesClear all
Sanofi's competitors and similar companies include Viatris, AstraZeneca and Lilly.
 Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. |  Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. | |
Founding Date | Founding Date 1994 | Founding Date 2020 | Founding Date 1999 | Founding Date 1876 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more |
Employees | Employees 82,878 | Employees 38,0003% increase | Employees 94,300 | Employees 47,0009% increase |
Valuation ($) | Valuation ($) 141.1 b | Valuation ($) 14 b | Valuation ($) 2.7 b | Valuation ($) 903.4 b |
Financial | ||||
Revenue (est.) | Revenue (est.) €45.4b (FY, 2025) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) $65.2b (FY, 2025) |
Cost of goods | Cost of goods €11.6b (FY, 2025) | Cost of goods $9.3b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods $11.1b (FY, 2025) |
Gross profit | Gross profit €37.6b (FY, 2025) | Gross profit $5b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit $54.1b (FY, 2025) |
Net income | Net income €8b (FY, 2025) | Net income ($3.5b) (FY, 2025) | Net income $10.2b (FY, 2025) | Net income $20.6b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries N/A | Countries 165 (Q1, 2023) | Countries 130 (FY, 2021) | Countries 120 (FY, 2021) |
Projects in R&D Pipeline | Projects in R&D Pipeline 91 (FY, 2019) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 177 (FY, 2021) | Projects in R&D Pipeline N/A |
Funding | ||||
Total funding raised | Total funding raised $ 310m | Total funding raised N/A | Total funding raised $ 1b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Viatris
HQ
Canonsburg, US
Employees
38,000↑ 3% increase
Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyLilly
HQ
Indianapolis, US
Employees
47,000↑ 9% increase
Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.
View company